NDC11 64980072901
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64980-0729-01 | 64980-0729 |
| 64980-0729-1 | 64980-0729 |
| 64980-729-01 | 64980-729 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PHOSPHA 250 NEUTRAL | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | 9432adfc-6add-4ab4-ae93-2e2daf348be2 | 2026-03-25 | Adverse reactions | 64980-729-01 64980-729 64980072901 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.